Skip to content

Recent News and Multimedia Featuring IRP

News and Media about IRP

screenshot from video Discover NIMH: Drug Discovery and Development
Discover NIMH: Drug Discovery and Development

One of the most exciting recent breakthroughs from research funded by the National Institute of Mental Health (NIMH) is the development of a fast-acting medication for treatment-resistant depression based on ketamine. This treatment is bringing new hope to people and families affected by major depression.

WatchRead Transcript

Study Reveals Sex-Based Differences in the Development of Brain Hubs Involved in Memory and Emotion

Press Release

Researchers have uncovered sex-based differences in the development of the hippocampus and amygdala—brain areas that have been implicated in the biology of several mental disorders that impact males and females differently.

Read More

National Institute of Mental Health
Elisa Dumett, Ph.D., Winner of the 2018 NIMH Three-Minute Talks Competition

Elisa Dumett Torres, Ph.D., winner of the 2018 NIMH Three-Minute Talks Competition, presents her three minute talk on viewing hippocampal functional coupling through the lens of environmental factor of urbanicity and the genetic factor BDNF. Her study provides a template for exploring the effects of gene environment interactions for general brain function and how this might be altered in psychiatric illness.

WatchRead Transcript

National Institute of Mental Health
Laura Padilla, Ph.D., Winner of the 2018 NIMH Three-Minute Talks Competition

Laura Padilla, Ph.D., winner of the 2018 NIMH Three-Minute Talks Competition, presents her three minute talk on reward related functional connectivity wth nucleus accumbens changes across puberty. Her study will attempt to disentangle the roles of age, puberty stage, and hormonal events of puberty in the development of reward processing.

WatchRead Transcript

illustration of human brain in blue
Dr. Niko Kriegeskorte: How can computer models help us better understand the brain?

Dr. Niko Kriegeskorte, a computational neuroscientist from the Zuckerman Institute at Columbia University, discusses the challenges of deriving insight into the principles of brain function using fMRI and other neuroimaging methods.

ListenRead Transcript

teen boy smiles at doctor
Webinar for Nurses - How to Use the ASQ to Detect Patients at Risk for Suicide

In this webinar, Dr. Lisa Horowitz reviews how to conducts suicide risk screening with the ASQ tool. This training is for nurses.

WatchRead Transcript

screenshot from NIMH viddeo Suicide Risk Screening Training: How to Manage Patients at Risk for Suicide
Suicide Risk Screening Training: How to Manage Patients at Risk for Suicide

Suicide Risk Screening Training for Mental Health Clinicians: How to Manage Patients at Risk for Suicide by Lisa M. Horowitz, Ph.D., MPH, Office of the Clinical Director, Intramural Research Program, National Institute of Mental Health

WatchRead Transcript

Release of “13 Reasons Why” Associated with Increase in Youth Suicide Rates

Press Release

A study conducted by researchers at several universities, hospitals, and the National Institute of Mental Health (NIMH) found that the Netflix show “13 Reasons Why” was associated with a 28.9% increase in suicide rates among U.S. youth ages 10-17 in the month (April 2017) following the shows release, after accounting for ongoing trends in suicide rates.

Read More

illustration of human brain in blue
Autism in Adults

Over the last twenty years, research has helped us better understand autism in adults. In a podcast, NIMH Director Dr. Joshua Gordon interviews Dr. Ann Wagner, National Autism Coordinator, and Dr. Lisa Gilotty, chief of NIMH’s Research Program on Autism Spectrum Disorders, to discuss these research advances.

ListenRead Transcript

Bench-to-Bedside: NIMH Research Leading to Brexanolone, First-Ever Drug Specifically for Postpartum Depression

Press Release

FDA approval of the postpartum depression treatment brexanolone represents the final phase of a bench-to-bedside journey for this drug — a journey that began in the NIMH Intramural Research Program. NIMH experts are available to provide information on postpartum depression and the importance of, and the science underlying, this new drug.

Read More

News and Media about IRP